I know everyone's eager to hear what transpired at the AGM. I'll be posting a more detailed message later, but for now, here are few tidbits.

Overall, things are as promising and exciting as ever. These guys really have some top notch stuff going on. Just takes a long time for all the ducks to line up and for cash to be in your pocket. At least your kids will be wealthy.

Proceeding with ZEN3694 into Phase 1 - target is prostate cancer

Top two prostate cancer investigators in US will be involved in clinical trial including Howard Scher from MSKCC. Involvement of PCCTC (Prostrate Cancer something or other) in some of the sites.

Regional licensing deals being pursued to help fund trials (perhaps China again?)

Still planning an IPO (on Nasdaq ideally) but working through a few alternatives to get there, including possibly a reverse takeover of a company that might have listing already -- cheaper to do it this way.

RVX back in lab with new compounds being investigated (but that's for another day).

Likely 3 years before we see anything in the form of revenues streaming in through ZCC.

More info to come after JP Morgan conference, including slides from the AGM (similar presentation).

masila